Buckley Capital Advisors, an investment management company, released its first quarter 2025 investor letter. A copy of the ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

The stock’s sentiments have received a significant boost following the approval of the flagship drug Ohtuvayre for the ...

FEV1 helps measure the progression of lung conditions such as chronic obstructive pulmonary disease (COPD) or asthma. FEV stands for forced expiratory volume, which is the air you exhale in one ...

Part B medication coverage is limited to drugs administered through durable medical equipment, including nebulizers and compressors ... in elderly patients with COPD.

Common COPD treatments include inhaled corticosteroids to reduce inflammation and bronchodilators to help open the airways and relax the muscles around the lungs. Some patients use a combination of ...

Patients with arthritis and COPD vs. without COPD had a significantly heightened adjusted risk for all-cause mortality. This was also the case for CVD and chronic lower respiratory disease mortality.

George’s Respiratory Questionnaire score plus peak expiratory flow to screen for COPD, according to data published in American Journal of Respiratory and Critical Care Medicine. “If you are a ...

Chemicals in tobacco smoke can destroy lung tissue, increase mucus, and cause inflammation. Over time, inhaling these harmful chemicals can contribute to progressive lung problems like chronic ...

Actor Gene Hackman’s wife, Betsy Arakawa, died after contracting Hantavirus pulmonary syndrome, a New Mexico medical examiner announced last month. Hackman and Arakawa, 65, were found dead in ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition to asthma Itepekimab expanding into chronic ...

Itepekimab expanding into chronic rhinosinusitis along with COPD and bronchiectasis; phase 3 readouts in COPD in H2 2025 and bronchiectasis in 2026 Paris, April 15, 2025. Sanofi today shared new ...